Stiefel Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STIEFEL LABS INC, and what generic and branded alternatives to STIEFEL LABS INC drugs are available?
STIEFEL LABS INC has one approved drug.
Drugs and US Patents for Stiefel Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-003 | Aug 6, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-004 | Aug 6, 2009 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-001 | Oct 28, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.